Quantification of urinary AICAR concentrations as a matter of doping controls |
| |
Authors: | Andreas Thomas Simon Beuck Jens Christian Eickhoff Sven Guddat Oliver Krug Matthias Kamber Wilhelm Schänzer Mario Thevis |
| |
Institution: | 1. Institute of Biochemistry, Center for Preventive Doping Research, German Sport University Cologne, Am Sportpark Müngersdorf, 50933, Cologne, Germany 2. Department of Statistics, Colorado State University, Fort Collins, CO, 80523-1877, USA 3. Department of Doping Prevention, Federal Office of Sports, 3000, Bern, Switzerland
|
| |
Abstract: | Influencing the endurance in elite sports is one of the key points in modern sports science. Recently, a new class of prohibited
substances reached in the focus of doping control laboratories and their misuse was classified as gene doping. The adenosine
monophosphate activated protein kinase activator 5-amino-4-imidazolecarboxyamide ribonucleoside (AICAR) was found to significantly
enhance the endurance even in sedentary mice after treatment. Due to endogenous production of AICAR in healthy humans, considerable
amounts were present in the circulation and, thus, were excreted into urine. Considering these facts, the present study was
initiated to fix reference values of renally cleared AICAR in elite athletes. Therefore a quantitative analytical method by
means of isotope-dilution liquid chromatography (analytical column: C6-phenyl) coupled to tandem mass spectrometry, after
a sample preparation consisting of a gentle dilution of native urine, was developed. Doping control samples of 499 athletes
were analysed, and AICAR concentrations in urine were determined. The mean AICAR value for all samples was 2,186 ng/mL with
a standard deviation of 1,655 ng/mL. Concentrations were found to differ depending on gender, type of sport and type of sample
collection (in competition/out of competition). The method was fully validated for quantitative purposes considering the parameters
linearity, inter- (12%, 7% and 10%) and intraday precision (14%, 9% and 12%) at low, mid and high concentration, robustness,
accuracy (approx. 100%), limit of quantification (100 ng/mL), stability and ion suppression effects, employing an in-house
synthesised 13C5-labelled AICAR as internal standard. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|